Final results of a phase II study of lenalidomide in combination with rituximab for the treatment of indolent non follicular non hodgkin lymphoma

This article has no abstract
Epistemonikos ID: d731f607ba76b83f8094d0a87996862d2ee73e5c
First added on: Feb 05, 2025